RNA-sequencing’s conversion of molecules to reads is inconsistent. Experiment-to-experiment variations (systemic bias) create batch effects, while gene-to-gene variations (sequence-dependent bias) invalidate inter-gene comparisons, precluding a universal scale. This confines analysis to relative fold-changes, a metric unreliable across batches. We introduce TranScale: 100 biomimetic standards with SI-traceable concentrations certified by Isotope Dilution Mass Spectrometry. Co-processed within samples, they empirically characterize systemic and sequence-dependent biases, generating a library-specific calibration curve (R² > 0.97) to convert reads into absolute quantities. This approach reveals that consistent fold-changes can mask severe absolute errors, exposing systemic biases missed by conventional QC. Across laboratories, this calibration reduced median inter-lab CV from >85% to <25% and increased biological signal-to-noise from ~0 to >7.9, outperforming the widely-used tool ComBat. By anchoring RNA-seq to the SI, our work establishes the metrological foundation for data interoperability and universal benchmarks, enabling absolute comparisons of SI-traceable quantities between any two genes. RNA-sequencing’s conversion of molecules to reads confines analysis to relative fold-changes, a metric unreliable across batches. Here, the authors introduce TranScale, a spike-in method with 100 biomimetic standards that converts reads into absolute quantities to resolve systemic biases.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: